KLRS

SEC source: 0001209191-23-004502 · doc4.xml · nonDerivative · entry 1

Sinha Vikas · CIK 0001337845 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,031,664

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.94 to $5.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-23-004501 · doc4.xml · nonDerivative · entry 3

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,999

F3 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.94 to $5.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-23-004500 · doc4.xml · nonDerivative · entry 1

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,342

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.94 to $5.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-23-004501 · doc4.xml · nonDerivative · entry 2

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 288,799

F1 · kind: On December 2, 2022, the Reporting Person transferred 98,346 shares to The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001209191-23-004501 · doc4.xml · nonDerivative · entry 1

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,031

F1 · kind: On December 2, 2022, the Reporting Person transferred 98,346 shares to The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-036553 · doc4.xml · nonDerivative · entry 1

Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 633,033

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.23 to $7.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-036362 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,726

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-036018 · doc4.xml · nonDerivative · entry 1

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 190,453

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.90 to $8.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-035701 · doc4.xml · nonDerivative · entry 2

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,899

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-035893 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,800

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 4, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-035551 · doc4.xml · nonDerivative · entry 2

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 386,392

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 4, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-035701 · doc4.xml · nonDerivative · entry 1

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,910

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.015. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-035551 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,501

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 4, 2022.

SEC source: 0000899243-22-034057 · doc4.xml · nonDerivative · entry 3

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,899

F4 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034057 · doc4.xml · nonDerivative · entry 2

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,899

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.27 to $8.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034264 · doc4a.xml · nonDerivative · entry 2

Atillasoy Ercem · CIK 0001818802 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,372

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034054 · doc4.xml · nonDerivative · entry 2

Atillasoy Ercem · CIK 0001818802 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,372

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034264 · doc4a.xml · nonDerivative · entry 1

Atillasoy Ercem · CIK 0001818802 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,899

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034265 · doc4a.xml · nonDerivative · entry 1

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,377

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034263 · doc4a.xml · nonDerivative · entry 1

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,233

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034262 · doc4a.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,800

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034261 · doc4a.xml · nonDerivative · entry 1

Sinha Vikas · CIK 0001337845 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,036,775

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-033994 · doc4.xml · nonDerivative · entry 1

Hallal David · CIK 0001457477 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 138,153

F1 · ownership.nature: Shares held by Terrie A. Hallal Family Irrevocable Trust 2012, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-034054 · doc4.xml · nonDerivative · entry 1

Atillasoy Ercem · CIK 0001818802 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,899

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034060 · doc4.xml · nonDerivative · entry 1

Sinha Vikas · CIK 0001337845 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,036,775

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034059 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,800

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034057 · doc4.xml · nonDerivative · entry 1

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,233

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-034056 · doc4.xml · nonDerivative · entry 1

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,377

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-032297 · doc4.xml · nonDerivative · entry 1

Hallal David · CIK 0001457477 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 720,965

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.35 to $8.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F2 · ownership.nature: Shares held by The Hallal Family Irrevocable Trust 2012, for which the Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-030423 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,870

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.85 to $7.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-029271 · doc4.xml · nonDerivative · entry 1

Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 637,548

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.67 to $7.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-029046 · doc4.xml · nonDerivative · entry 1

Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 642,112

F1 · shares: The shares reported in this transaction represent restricted stock units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.

SEC source: 0000899243-22-029061 · doc4.xml · nonDerivative · entry 1

Sinha Vikas · CIK 0001337845 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,038,224

F1 · shares: The shares reported in this transaction represent restricted stock units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.

SEC source: 0000899243-22-029062 · doc4.xml · nonDerivative · entry 1

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

F1 · shares: The shares reported in this transaction represent restricted stock units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.

SEC source: 0000899243-22-029058 · doc4.xml · nonDerivative · entry 1

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,930

F1 · shares: The shares reported in this transaction represent restricted stock units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.

SEC source: 0000899243-22-029045 · doc4.xml · nonDerivative · entry 2

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 401,363

F3 · shares: The shares reported in this transaction represent RSUs issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.

SEC source: 0000899243-22-029045 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 386,363

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.12 to $8.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-029043 · doc4.xml · nonDerivative · entry 1

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,578

F1 · shares: The shares reported in this transaction represent restricted stock units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.

SEC source: 0000899243-22-027167 · doc4.xml · nonDerivative · entry 1

GADICKE ANSBERT · CIK 0001134655 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By ElevateBio LLC

Disclosed balance after: 16,674,766

F1 · kind: On July 28, 2022, ElevateBio LLC ("ElevateBio") acquired 3,253,796 shares of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F2 · ownership.nature: Shares held by ElevateBio. The Reporting Person is a director of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027169 · doc4.xml · nonDerivative · entry 1

ElevateBio, LLC · CIK 0001818060 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,674,766

F1 · kind: On July 28, 2022, ElevateBio LLC ("ElevateBio") acquired 3,253,796 shares of the Issuer's Common Stock in a registered direct offering at a price of $4.61 per share.

F2 · ownership.direct: These shares are directly held by ElevateBio. David Hallal, Vikas Sinha, Morana Jovan-Embiricos and Ansbert Gadicke are directors of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. Such persons disclaim beneficial ownership of all shares held by ElevateBio except to the extent of their pecuniary interest therein, if any.

SEC source: 0000899243-22-027175 · doc4.xml · nonDerivative · entry 1

Sinha Vikas · CIK 0001337845 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By ElevateBio LLC

Disclosed balance after: 16,674,766

F1 · kind: On July 28, 2022, ElevateBio LLC ("ElevateBio") acquired 3,253,796 shares of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F2 · ownership.nature: Shares held by ElevateBio. The Reporting Person is a director and Chief Financial Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027173 · doc4.xml · nonDerivative · entry 1

Hallal David · CIK 0001457477 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By ElevateBio LLC

Disclosed balance after: 16,674,766

F1 · kind: On July 28, 2022, ElevateBio LLC ("ElevateBio") acquired 3,253,796 shares of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F2 · ownership.nature: Shares held by ElevateBio. The Reporting Person is the Chairman and Chief Executive Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027171 · doc4.xml · nonDerivative · entry 6

Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By ElevateBio LLC

Disclosed balance after: 16,674,766

F1 · kind: On July 28, 2022, F2 MG Limited ("F2 MG"), F2-TPO Investments LLC ("F2-TPO"), F2 MC LLC ("F2 MC"), F2 Capital I 2020 LLC ("F2 2020"), F2 Bioscience AV 2022 LLC ("F2 2022") and ElevateBio LLC ("ElevateBio") acquired 684,622 shares, 325,379 shares, 1,626,898 shares, 1,393,874 shares, 867,678 shares and 3,253,796 shares, respectively, of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F7 · ownership.nature: Shares held by ElevateBio. The Reporting Person is a director of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027171 · doc4.xml · nonDerivative · entry 5

Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By F2 Bioscience AV 2022 LLC

Disclosed balance after: 867,678

F1 · kind: On July 28, 2022, F2 MG Limited ("F2 MG"), F2-TPO Investments LLC ("F2-TPO"), F2 MC LLC ("F2 MC"), F2 Capital I 2020 LLC ("F2 2020"), F2 Bioscience AV 2022 LLC ("F2 2022") and ElevateBio LLC ("ElevateBio") acquired 684,622 shares, 325,379 shares, 1,626,898 shares, 1,393,874 shares, 867,678 shares and 3,253,796 shares, respectively, of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F6 · ownership.nature: Shares held by F2 2022. Globeways Holdings II Limited is the appointed manager of F2 2022 and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 2022. The Reporting Person is the founding director of Globeways Holdings II Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027171 · doc4.xml · nonDerivative · entry 4

Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By F2 Capital I 2020 LLC

Disclosed balance after: 4,193,874

F1 · kind: On July 28, 2022, F2 MG Limited ("F2 MG"), F2-TPO Investments LLC ("F2-TPO"), F2 MC LLC ("F2 MC"), F2 Capital I 2020 LLC ("F2 2020"), F2 Bioscience AV 2022 LLC ("F2 2022") and ElevateBio LLC ("ElevateBio") acquired 684,622 shares, 325,379 shares, 1,626,898 shares, 1,393,874 shares, 867,678 shares and 3,253,796 shares, respectively, of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F5 · ownership.nature: Shares held by F2 2020. Globeways Holdings II Limited is the appointed manager of F2 2020 and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 2020. The Reporting Person is the founding director of Globeways Holdings II Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027171 · doc4.xml · nonDerivative · entry 3

Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By F2 MC, LLC

Disclosed balance after: 2,038,583

F1 · kind: On July 28, 2022, F2 MG Limited ("F2 MG"), F2-TPO Investments LLC ("F2-TPO"), F2 MC LLC ("F2 MC"), F2 Capital I 2020 LLC ("F2 2020"), F2 Bioscience AV 2022 LLC ("F2 2022") and ElevateBio LLC ("ElevateBio") acquired 684,622 shares, 325,379 shares, 1,626,898 shares, 1,393,874 shares, 867,678 shares and 3,253,796 shares, respectively, of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F4 · ownership.nature: Shares held by F2 MC. Globeways Holdings II Limited is the appointed manager of F2 MC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MC. The Reporting Person is the founding director of Globeways Holdings II Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027171 · doc4.xml · nonDerivative · entry 2

Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By F2-TPO Investments, LLC

Disclosed balance after: 668,072

F1 · kind: On July 28, 2022, F2 MG Limited ("F2 MG"), F2-TPO Investments LLC ("F2-TPO"), F2 MC LLC ("F2 MC"), F2 Capital I 2020 LLC ("F2 2020"), F2 Bioscience AV 2022 LLC ("F2 2022") and ElevateBio LLC ("ElevateBio") acquired 684,622 shares, 325,379 shares, 1,626,898 shares, 1,393,874 shares, 867,678 shares and 3,253,796 shares, respectively, of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F3 · ownership.nature: Shares held by F2-TPO. Globeways Holdings II Limited is the appointed manager of F2-TPO and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person is the founding director of Globeways Holdings II Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-027171 · doc4.xml · nonDerivative · entry 1

Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By F2 MG Limited

Disclosed balance after: 2,059,884

F1 · kind: On July 28, 2022, F2 MG Limited ("F2 MG"), F2-TPO Investments LLC ("F2-TPO"), F2 MC LLC ("F2 MC"), F2 Capital I 2020 LLC ("F2 2020"), F2 Bioscience AV 2022 LLC ("F2 2022") and ElevateBio LLC ("ElevateBio") acquired 684,622 shares, 325,379 shares, 1,626,898 shares, 1,393,874 shares, 867,678 shares and 3,253,796 shares, respectively, of the Issuer's Common Stock in a registered direct offering for a purchase price of $4.61 per share.

F2 · ownership.nature: Shares held by F2 MG. Globeways Holdings Limited is the appointed manager of F2 MG and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person is the founding director of Globeways Holdings Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-026519 · doc4.xml · nonDerivative · entry 1

Hallal David · CIK 0001457477 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,073,662

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 7, 2022 to cover tax withholding obligations upon the vesting and settlement of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.26 to $5.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0000899243-22-026579 · doc4.xml · nonDerivative · entry 1

Atillasoy Ercem · CIK 0001818802 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,467

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.351 to $5.405. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.